Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Asahi Intecc Co ( (JP:7747) ) has shared an update.
Asahi Intecc reported strong results for the six months ended Dec. 31, 2025, with net sales rising 15.9% year on year to ¥71.27 billion and profit attributable to owners of parent up 40.4% to ¥17.21 billion. Operating profit jumped 40.1% to ¥24.37 billion, lifting the equity-to-asset ratio to 80.6% and pushing basic earnings per share to ¥64.56.
The company revised its full-year forecast higher, now projecting net sales of ¥141.14 billion and a 139.9% surge in profit attributable to owners of parent to ¥30.56 billion. It also raised its dividend outlook, planning a total annual dividend of ¥46.10 per share for the year to June 30, 2026, including a commemorative payout, signaling confidence in earnings strength and balance sheet resilience.
The most recent analyst rating on (JP:7747) stock is a Hold with a Yen2759.00 price target. To see the full list of analyst forecasts on Asahi Intecc Co stock, see the JP:7747 Stock Forecast page.
More about Asahi Intecc Co
Asahi Intecc Co., Ltd. is a Japan-based medical device manufacturer listed on the Tokyo and Nagoya stock exchanges. The company focuses on high-precision products such as guide wires and catheter-related components, serving global cardiovascular and other minimally invasive treatment markets.
Average Trading Volume: 1,048,052
Technical Sentiment Signal: Buy
Current Market Cap: Yen691.8B
See more data about 7747 stock on TipRanks’ Stock Analysis page.

